Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CX116

😃Good
Catalog No. T211127

CX116 is an orally effective anti-inflammatory agent with significant anti-inflammatory properties. It exerts its effects by inhibiting inflammatory responses, reducing oxidative stress, protecting mitochondrial function, and preventing apoptosis (apoptosis). CX116 demonstrates acceptable toxicity and favorable pharmacokinetic characteristics, and it significantly safeguards mouse kidney tissue from Cisplatin-induced damage. CX116 is suitable for studying acute kidney injury caused by Cisplatin.

CX116

CX116

😃Good
Catalog No. T211127
CX116 is an orally effective anti-inflammatory agent with significant anti-inflammatory properties. It exerts its effects by inhibiting inflammatory responses, reducing oxidative stress, protecting mitochondrial function, and preventing apoptosis (apoptosis). CX116 demonstrates acceptable toxicity and favorable pharmacokinetic characteristics, and it significantly safeguards mouse kidney tissue from Cisplatin-induced damage. CX116 is suitable for studying acute kidney injury caused by Cisplatin.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
CX116 is an orally effective anti-inflammatory agent with significant anti-inflammatory properties. It exerts its effects by inhibiting inflammatory responses, reducing oxidative stress, protecting mitochondrial function, and preventing apoptosis (apoptosis). CX116 demonstrates acceptable toxicity and favorable pharmacokinetic characteristics, and it significantly safeguards mouse kidney tissue from Cisplatin-induced damage. CX116 is suitable for studying acute kidney injury caused by Cisplatin.
In vitro
CX116 (Compound 83) exhibits protective effects on LPS-stimulated RAW 264.7 cells and inhibits NO production with an EC₅₀ of 0.8 μM and an IC₅₀ of 1.1 μM when used at 10 μM for 1 hour. When pretreated with 10 μM Cisplatin for 1 hour, CX116 at concentrations ranging from 1.25 to 10 μM inhibits levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and MCP-1) associated with cisplatin-induced acute kidney injury in HK-2 cells in a concentration-dependent manner. At 2.5 to 10 μM and with 10 μM cisplatin pretreatment, CX116 decreases cisplatin-induced ROS levels in a dose-dependent way and provides robust protection to mitochondrial structure and function in HK-2 cells. Additionally, CX116 reverses cisplatin-reduced proteins such as sirtuin3, Opa1, and ATP5A1 dose-dependently after 24 hours while also reducing cisplatin-induced apoptosis in HK-2 cells by decreasing P53, c-caspase 3, and Bax protein expression while increasing anti-apoptotic Bcl-2 protein levels significantly, thereby lowering the Bax/Bcl-2 ratio. CX116 does not induce apoptosis on its own. Regarding major cytochrome P450 enzymes (CYPs), the IC₅₀ values for CX116 after 24 hours are 26.8 μM for LA-2, 14.2 μM for 2C9, 13.7 μM for 2C19, 34.5 μM for 2D6, and greater than 50 for 3A4.
In vivo
CX116 (Compound 83) at a high single dose of 1500 mg/kg administered orally did not result in mortality, toxicity, or significant weight loss in C57BL/6 mice. Furthermore, CX116 administered intragastrically at doses of 25 and 50 mg/kg daily for six days significantly reduced cisplatin-induced nephrotoxicity in mice and provided substantial renal protection.
Chemical Properties
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy CX116 | purchase CX116 | CX116 cost | order CX116 | CX116 in vivo | CX116 in vitro